Adipose-derived mesenchymal stem cells embedded in platelet-rich fibrin scaffolds promote angiogenesis, preserve heart function, and reduce left ventricular remodeling in rat acute myocardial infarction

American Journal of Translational Research

Volumn 7, Issue 5, 2015, Pages 781-803

  Chen, Yung Lung ^a   Sun, Cheuk Kwan ^b   Tsai, Tzu Hsien ^a   Chang, Li Teh ^c   Leu, Steve ^a   Zhen, Yen Yi ^a   Sheu, Jiunn Jye ^a   Chua, Sarah ^a   Yeh, Kuo Ho ^a   Lu, Hung I ^a   Chang, Hsueh Wen ^d   Lee, Fan Yen ^a   Yip, Hon Kan ^a,e  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

^c MEIHO UNIVERSITY   (Taiwan)

^d NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Acute myocardial infarction; Engineered tissue; Mesenchymal stem cells; Platelet rich fibrin

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BRAIN NATRIURETIC PEPTIDE; CHEMOKINE RECEPTOR CXCR4; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 1BETA; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN BAX; PROTEIN BCL 2; SMAD PROTEIN; SMAD1 PROTEIN; SMAD5 PROTEIN; STROMAL CELL DERIVED FACTOR 1ALPHA; VASCULOTROPIN;

ACUTE HEART INFARCTION; ADIPOSE DERIVED MESENCHYMAL STEM CELL; ADULT; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CARDIOVASCULAR PARAMETERS; CELL LABELING; CONTROLLED STUDY; ECHOCARDIOGRAPHY; END DIASTOLIC DIAMETER; END SYSTOLIC DIAMETER; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HEART FAILURE; HEART FUNCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYMAL STEM CELL; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; SCANNING ELECTRON MICROSCOPY; THROMBOCYTE; TISSUE SCAFFOLD; WESTERN BLOTTING;

ANIMALIA; RATTUS;

EID: 84936754517     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. [1] Murray CJ and Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349: 1269-76.
2. [2] Erlebacher JA, Weiss JL, Weisfeldt ML and Bulkley BH. Early dilation of the infarcted segment in acute transmural myocardial infarction: role of infarct expansion in acute left ventricular enlargement. J Am Coll Cardiol 1984; 4: 201-8.
3. [3] Pfeffer MA, Braunwald E, Moyé LA, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 1992; 327: 669-77.
4. [4] Cohn JN, Ferrari R and Sharpe N. Cardiac re-modeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol 2000; 35: 569-82.
5. [5] The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. The GUSTO Angio-graphic Investigators. N Engl J Med 1993; 329: 1615-22.
6. [6] Stone GW, Brodie BR, Griffn JJ, Morice MC, Costantini C, St Goar FG, Overlie PA, Popma JJ, McDonnell J, Jones D, O’Neill WW, Grines CL. Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. Primary An-gioplasty in Myocardial Infarction Stent Pilot Trial Investigators. J Am Coll Cardiol 1998; 31: 23-30.
7. [7] Yip HK, Chen MC, Chang HW, Hang CL, Hsieh YK, Fang CY, Wu CJ. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-fow and no-refow phenomenon. Chest 2002; 122: 1322-32.
8. [8] Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF and Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 1988; 319: 80-6.
9. [9] Mann DL. Mechanisms and models in heart failure: A combinatorial approach. Circulation 1999; 100: 999-1008.
10. 10[] Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa P. Bone marrow cells regenerate in- farcted myocardium. Nature 2001; 410: 701-705.
11. [11] Yang S, Fazel S, Angoulvant D, Weisel RD and Li RK. Cell transplantation for heart disease: the clinical perspective. Evid Based Cardiovasc Med 2005; 9: 2-7.
12. [12] Nanjundappa A, Raza JA, Dieter RS, Manda-paka S and Cascio WE. Cell transplantation for treatment of left-ventricular dysfunction due to ischemic heart failure: from bench to bedside. Expert Rev Cardiovasc Ther 2007; 5: 125-31.
13. [13] Yip HK, Chang LT, Wu CJ, Sheu JJ, Youssef AA, Pei SN, Lee FY, Sun CK. Autologous bone marrow-derived mononuclear cell therapy prevents the damage of viable myocardium and improves rat heart function following acute anterior myocardial infarction. Circ J 2008; 72: 1336-45.
14. [14] Tang XL, Rokosh G, Sanganalmath SK, Yuan F, Sato H, Mu J, Dai S, Li C, Chen N, Peng Y, Dawn B, Hunt G, Leri A, Kajstura J, Tiwari S, Shirk G, Anversa P, Bolli R. Intracoronary administra tion of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day- old infarction. Circulation 2010; 121: 293-305.
15. [15] Zimmet H, Porapakkham P, Porapakkham P, Sata Y, Haas SJ, Itescu S, Forbes A, Krum H. Short- and long-term outcomes of intracoro-nary and endogenously mobilized bone marrow stem cells in the treatment of ST-segment elevation myocardial infarction: a meta-analy-sis of randomized control trials. Eur J Heart Fail 2012; 14: 91-105.
16. [16] Sun CK, Chang LT, Sheu JJ, Chiang CH, Lee FY, Wu CJ, Chua S, Fu M, Yip HK. Bone marrow-derived mononuclear cell therapy alleviates left ventricular remodeling and improves heart function in rat-dilated cardiomyopathy. Crit Care Med 2009; 37: 1197-205.
17. [17] Simpson D, Liu H, Fan TH, Nerem R, Dudley SC Jr. A tissue engineering approach to progenitor cell delivery results in significant cell engraft-ment and improved myocardial remodeling. Stem Cells 2007; 25: 2350-7.
18. [18] Simpson DL, Dudley SC Jr. Modulation of human mesenchymal stem cell function in a three-dimensional matrix promotes attenuation of adverse remodelling after myocardial infarction. J Tissue Eng Regen Med 2013; 7: 192-202.
19. [19] Leu S, Lin YC, Yuen CM, Yen CH, Kao YH, Sun CK, Yip HK. Adipose-derived mesenchymal stem cells markedly attenuate brain infarct size and improve neurological function in rats. J Transl Med 2010; 8: 63.
20. [20] Chen YT, Sun CK, Lin YC, Chang LT, Chen YL, Tsai TH, Chung SY, Chua S, Kao YH, Yen CH, Shao PL, Chang KC, Leu S, Yip HK. Adipose-derived mesenchymal stem cell protects kidneys against ischemia-reperfusion injury through suppressing oxidative stress and infammatory reaction. J Transl Med 2011; 9: 51.
21. [21] Yeh KH, Sheu JJ, Lin YC, Sun CK, Chang LT, Kao YH, Yen CH, Shao PL, Tsai TH, Chen YL, Chua S, Leu S, Yip HK. Beneft of combined extracorpo-real shock wave and bone marrow-derived en-dothelial progenitor cells in protection against critical limb ischemia in rats. Crit Care Med 2012; 40: 169-77.
22. [22] Olson EN and Schneider MD. Sizing up the heart: development redux in disease. Genes Dev 2003; 17: 1937-56.
23. [23] Izumo S, Lompré AM, Matsuoka R, Koren G, Schwartz K, Nadal-Ginard B, Mahdavi V. Myo-sin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. Interaction between hemodynamic and thyroid hormone-induced signals. J Clin Invest 1987; 79: 970-7.
24. [24] Lundblad R, Abdelnoor M and Svennevig JL. Repair of left ventricular aneurysm: surgical risk and long-term survival. Ann Thorac Surg 2003; 76: 719-25.
25. [25] Menicanti L and Di Donato M. Surgical left ventricle reconstruction, pathophysiologic insights, results and expectation from the STICH trial. Eur J Cardiothorac Surg 2004; 26 Suppl 1: S42-6.
26. [26] Mann DL, Kubo SH, Sabbah HN, Starling RC, Jessup M, Oh JK, Acker MA. Beneficial effects of the CorCap cardiac support device: fve-year results from the Acorn Trial. J Thorac Cardio-vasc Surg 2012; 143: 1036-42.
27. [27] Dor V, Civaia F, Alexandrescu C, Sabatier M and Montiglio F. Favorable effects of left ventricular reconstruction in patients excluded from the Surgical Treatments for Ischemic Heart Failure (STICH) trial. J Thorac Cardiovasc Surg 2011; 141: 905-16, 916, e1-4.
28. [28] Imanishi Y, Miyagawa S, Maeda N, Fukushima S, Kitagawa-Sakakida S, Daimon T, Hirata A, Shimizu T, Okano T, Shimomura I, Sawa Y. Induced adipocyte cell-sheet ameliorates cardiac dysfunction in a mouse myocardial infarction model: a novel drug delivery system for heart failure. Circulation 2011; 124 Suppl 11: S10-7.
29. [29] Sekine H, Shimizu T, Dobashi I, Matsuura K, Hagiwara N, Takahashi M, Kobayashi E, Yama-to M, Okano T. Cardiac cell sheet transplantation improves damaged heart function via superior cell survival in comparison with dissociated cell injection. Tissue Eng Part A 2011; 17: 2973-80.
30. 30[] Tomita S, Li RK, Weisel RD, Mickle DA, Kim EJ, Sakai T, Jia ZQ. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 1999; 100 Suppl 19: II247-56.
31. [31] Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS, Dzau VJ. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003; 9: 1195-201.
32. [32] Jackson KA, Majka SM, Wang H, Pocius J, Hartley CJ, Majesky MW, Entman ML, Michael LH, Hirschi KK, Goodell MA. Regeneration of isch-emic cardiac muscle and vascular endotheli-um by adult stem cells. J Clin Invest 2001; 107: 1395-402.
33. [33] Quaini F, Urbanek K, Beltrami AP, Finato N, Bel-trami CA, Nadal-Ginard B, Kajstura J, Leri A, Anversa P. Chimerism of the transplanted heart. N Engl J Med 2002; 346: 5-15.
34. [34] Noort WA, Oerlemans MI, Rozemuller H, Feyen D, Jaksani S, Stecher D, Naaijkens B, Martens AC, Bühring HJ, Doevendans PA, Sluijter JP. Human versus porcine mesenchymal stromal cells: phenotype, differentiation potential, im-munomodulation and cardiac improvement after transplantation. J Cell Mol Med 2012; 16: 1827-39.
35. [35] Chen J, Liu Z, Hong MM, Zhang H, Chen C, Xiao M, Wang J, Yao F, Ba M, Liu J, Guo ZK, Zhong J. Proangiogenic compositions of microvesi-cles derived from human umbilical cord mes-enchymal stem cells. PLoS One 2014; 9: e115316.
36. [36] Kociol RD, Greiner MA, Hammill BG, Eapen ZJ, Fonarow GC, Klaskala W, Mills RM, Curtis LH, Hernandez AF. B-type natriuretic peptide level and postdischarge thrombotic events in older patients hospitalized with heart failure: insights from the Acute Decompensated Heart Failure National Registry. Am Heart J 2012; 163: 994-1001.
37. [37] Phelan D, Watson C, Martos R, Collier P, Patle A, Donnelly S, Ledwidge M, Baugh J, McDonald K. Modest elevation in BNP in asymptomatic hypertensive patients reflects sub-clinical cardiac remodeling, infammation and extracellular matrix changes. PLoS One 2012; 7: e49259.